Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
Bradstock KF, Link E, Collins M, Di Iulio J, Lewis ID, Schwarer A, Enno A, Marlton P, Hahn U, Szer J, Cull G, Seymour JF; Australasian Leukaemia and Lymphoma Group. Bradstock KF, et al. Among authors: link e. Br J Haematol. 2014 Dec;167(5):618-25. doi: 10.1111/bjh.13086. Epub 2014 Aug 21. Br J Haematol. 2014. PMID: 25142189 Free article. Clinical Trial.
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.
Herbert KE, Demosthenous L, Wiesner G, Link E, Westerman DA, Came N, Ritchie DS, Harrison S, Seymour JF, Prince HM. Herbert KE, et al. Among authors: link e. Bone Marrow Transplant. 2014 Aug;49(8):1056-62. doi: 10.1038/bmt.2014.112. Epub 2014 Jun 2. Bone Marrow Transplant. 2014. PMID: 24887382 Clinical Trial.
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.
Harrison SJ, Quach H, Link E, Feng H, Dean J, Copeman M, Van De Velde H, Schwarer A, Baker B, Spencer A, Catalano J, Campbell P, Augustson B, Romeril K, Prince HM. Harrison SJ, et al. Among authors: link e. Am J Hematol. 2015 May;90(5):E86-91. doi: 10.1002/ajh.23967. Epub 2015 Feb 27. Am J Hematol. 2015. PMID: 25651830 Free article. Clinical Trial.
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).
Kenealy M, Patton N, Filshie R, Nicol A, Ho SJ, Hertzberg M, Mills T, Prosser I, Link E, Cowan L, Zannino D, Seymour JF. Kenealy M, et al. Among authors: link e. Leuk Lymphoma. 2017 Feb;58(2):298-307. doi: 10.1080/10428194.2016.1190971. Epub 2016 Jun 7. Leuk Lymphoma. 2017. PMID: 27268068 Clinical Trial.
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Quach H, Fernyhough L, Henderson R, Corbett G, Baker B, Browett P, Blacklock H, Forsyth C, Underhill C, Cannell P, Trotman J, Neylon A, Harrison S, Link E, Swern A, Cowan L, Dimopoulos MA, Miles Prince H. Quach H, et al. Among authors: link e. Br J Haematol. 2017 May;177(3):441-448. doi: 10.1111/bjh.14562. Epub 2017 Feb 15. Br J Haematol. 2017. PMID: 28197996 Free article. Clinical Trial.
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Bradstock KF, Link E, Di Iulio J, Szer J, Marlton P, Wei AH, Enno A, Schwarer A, Lewis ID, D'Rozario J, Coyle L, Cull G, Campbell P, Leahy MF, Hahn U, Cannell P, Tiley C, Lowenthal RM, Moore J, Cartwright K, Cunningham I, Taper J, Grigg A, Roberts AW, Benson W, Hertzberg M, Deveridge S, Rowlings P, Mills AK, Gill D, Bardy P, Campbell L, Seymour JF; Australasian Leukaemia & Lymphoma Group. Bradstock KF, et al. Among authors: link e. J Clin Oncol. 2017 May 20;35(15):1678-1685. doi: 10.1200/JCO.2016.70.6374. Epub 2017 Apr 3. J Clin Oncol. 2017. PMID: 28368672 Clinical Trial.
Impact of advancing age on treatment and outcomes in anal cancer.
Foo M, Link E, Leong T, Chu J, Lee MT, Chander S, Tran PK, Tomaszewski JM, Michael M, Heriot A, Ngan SY. Foo M, et al. Among authors: link e. Acta Oncol. 2014 Jul;53(7):909-16. doi: 10.3109/0284186X.2013.876513. Epub 2014 Jan 23. Acta Oncol. 2014. PMID: 24456502 Clinical Trial.
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
Conduit C, Davis ID, Goh JC, Kichenadasse G, Gurney H, Harris CA, Pook D, Krieger L, Parnis F, Underhill C, Adams D, Roncolato F, Joshua A, Ferguson T, Prithviraj P, Morris M, Harrison M, Begbie S, Hovey E, George M, Liow EC, Link EK, McJannett M, Gedye C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP); UNISoN Investigators. Conduit C, et al. Among authors: link ek. BJU Int. 2024 Feb;133 Suppl 3:57-67. doi: 10.1111/bju.16190. Epub 2023 Nov 20. BJU Int. 2024. PMID: 37986556 Clinical Trial.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Liu Z, Martin JH, Liauw W, McLachlan SA, Link E, Matera A, Thompson M, Jefford M, Hicks RJ, Cullinane C, Hatzimihalis A, Campbell I, Crowley S, Beale PJ, Karapetis CS, Price T, Burge ME, Michael M. Liu Z, et al. Among authors: link e. Eur J Clin Pharmacol. 2022 Jan;78(1):53-64. doi: 10.1007/s00228-021-03206-w. Epub 2021 Sep 4. Eur J Clin Pharmacol. 2022. PMID: 34480602
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM, Link E, Leong T, Heriot A, Vazquez M, Chander S, Chu J, Foo M, Lee MT, Lynch CA, Mackay J, Michael M, Tran P, Ngan SY. Tomaszewski JM, et al. Among authors: link e. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):552-8. doi: 10.1016/j.ijrobp.2011.07.007. Epub 2011 Oct 21. Int J Radiat Oncol Biol Phys. 2012. PMID: 22019078
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.
Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, Lim J, Soong J, Link E, Blombery P, Thompson ER, Fellowes A, Sheppard KE, McArthur GA, Pearson RB, Hannan RD, Poortinga G, Harrison SJ. Khot A, et al. Among authors: link e. Cancer Discov. 2019 Aug;9(8):1036-1049. doi: 10.1158/2159-8290.CD-18-1455. Epub 2019 May 15. Cancer Discov. 2019. PMID: 31092402 Clinical Trial.
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (18 F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors.
Lung MS, Hicks RJ, Pavlakis N, Link E, Jefford M, Thomson B, Wyld DK, Liauw W, Akhurst T, Kuru N, Michael M. Lung MS, et al. Among authors: link e. Asia Pac J Clin Oncol. 2020 Jun;16(3):150-157. doi: 10.1111/ajco.13307. Epub 2020 Feb 7. Asia Pac J Clin Oncol. 2020. PMID: 32030887 Clinical Trial.
Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
Pilgrim CH, Satgunaseelan L, Pham A, Murray W, Link E, Smith M, Usatoff V, Evans PM, Banting S, Thomson BN, Phillips WA, Michael M. Pilgrim CH, et al. Among authors: link e. HPB (Oxford). 2012 May;14(5):333-40. doi: 10.1111/j.1477-2574.2012.00454.x. Epub 2012 Mar 26. HPB (Oxford). 2012. PMID: 22487071 Free PMC article.
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Olivotto IA, Link E, Phillips C, Whelan TJ, Bryant G, Kunkler IH, Westenberg AH, Purohit K, Ahern V, Graham PH, Akra M, McArdle O, Ludbrook JJ, Harvey JA, Maduro JH, Kirkove C, Gruber G, Martin JD, Campbell ID, Delaney GP, Chua BH; BIG 03-07/TROG 07.01 trial investigators. Olivotto IA, et al. Among authors: link e. Radiother Oncol. 2020 Jan;142:180-185. doi: 10.1016/j.radonc.2019.07.024. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431385
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Michael M, Liauw W, McLachlan SA, Link E, Matera A, Thompson M, Jefford M, Hicks RJ, Cullinane C, Hatzimihalis A, Campbell IG, Rowley S, Beale PJ, Karapetis CS, Price T, Burge ME. Michael M, et al. Among authors: link e. Cancer Chemother Pharmacol. 2021 Jul;88(1):39-52. doi: 10.1007/s00280-021-04264-8. Epub 2021 Mar 23. Cancer Chemother Pharmacol. 2021. PMID: 33755789
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).
Pham T, Pereira L, Roth S, Galletta L, Link E, Akhurst T, Solomon B, Michael M, Darcy P, Sampurno S, Heriot A, Ramsay R, Desai J. Pham T, et al. Among authors: link e. Contemp Clin Trials Commun. 2019 Jul 10;16:100409. doi: 10.1016/j.conctc.2019.100409. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31650066 Free PMC article.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG; proPSMA Study Group Collaborators. Hofman MS, et al. Among authors: link e. Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group; Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Peto R, Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, et al. Lancet. 2010 Nov 13;376(9753):1658-69. doi: 10.1016/S0140-6736(10)60310-8. Epub 2010 Nov 8. Lancet. 2010. PMID: 21067805 Free PMC article. Clinical Trial.
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
SEARCH Collaborative Group; Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R. SEARCH Collaborative Group, et al. Among authors: link e. N Engl J Med. 2008 Aug 21;359(8):789-99. doi: 10.1056/NEJMoa0801936. Epub 2008 Jul 23. N Engl J Med. 2008. PMID: 18650507 Free article. Clinical Trial.
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group; Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, et al. JAMA. 2010 Jun 23;303(24):2486-94. doi: 10.1001/jama.2010.840. JAMA. 2010. PMID: 20571015 Clinical Trial.
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
Hopewell JC, Parish S, Offer A, Link E, Clarke R, Lathrop M, Armitage J, Collins R; MRC/BHF Heart Protection Study Collaborative Group. Hopewell JC, et al. Among authors: link e. Eur Heart J. 2013 Apr;34(13):982-92. doi: 10.1093/eurheartj/ehs344. Epub 2012 Oct 24. Eur Heart J. 2013. PMID: 23100282 Free PMC article. Clinical Trial.
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Tan L, Tran B, Tie J, Markman B, Ananda S, Tebbutt NC, Michael M, Link E, Wong SQ, Chandrashekar S, Guinto J, Ritchie D, Koldej R, Solomon BJ, McArthur GA, Hicks RJ, Gibbs P, Dawson SJ, Desai J. Tan L, et al. Among authors: link e. Clin Cancer Res. 2023 Mar 14;29(6):1017-1030. doi: 10.1158/1078-0432.CCR-22-3094. Clin Cancer Res. 2023. PMID: 36638198 Free PMC article. Clinical Trial.
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
Terai M, Londin E, Rochani A, Link E, Lam B, Kaushal G, Bhushan A, Orloff M, Sato T. Terai M, et al. Among authors: link e. Cancers (Basel). 2020 Feb 10;12(2):405. doi: 10.3390/cancers12020405. Cancers (Basel). 2020. PMID: 32050636 Free PMC article.
The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolyzed infant formulas in infants at high risk for allergic diseases. Design and selected results.
von Berg A, Filipiak-Pittroff B, Krämer U, Link E, Heinrich J, Koletzko S, Grübl A, Hoffmann U, Beckmann C, Reinhardt D, Bauer CP, Wichmann E, Berdel D. von Berg A, et al. Among authors: link e. Allergol Select. 2017 Aug 4;1(1):28-38. doi: 10.5414/ALX01462E. eCollection 2017. Allergol Select. 2017. PMID: 30402599 Free PMC article.
Allergic manifestation 15 years after early intervention with hydrolyzed formulas--the GINI Study.
von Berg A, Filipiak-Pittroff B, Schulz H, Hoffmann U, Link E, Sußmann M, Schnappinger M, Brüske I, Standl M, Krämer U, Hoffmann B, Heinrich J, Bauer CP, Koletzko S, Berdel D; GINIplus study group. von Berg A, et al. Among authors: link e. Allergy. 2016 Feb;71(2):210-9. doi: 10.1111/all.12790. Epub 2015 Nov 23. Allergy. 2016. PMID: 26465137 Free PMC article. Clinical Trial.
The association between physical activity and healthcare costs in children--results from the GINIplus and LISAplus cohort studies.
Idler N, Teuner CM, Hunger M, Holle R, Ortlieb S, Schulz H, Bauer CP, Hoffmann U, Koletzko S, Lehmann I, von Berg A, Berdel D, Hoffmann B, Schaaf B, Heinrich J, Wolfenstetter SB; GINIplus and LISAplus Study Groups. Idler N, et al. BMC Public Health. 2015 Apr 29;15:437. doi: 10.1186/s12889-015-1721-6. BMC Public Health. 2015. PMID: 25925399 Free PMC article.
Caesarean Section has no impact on lung function at the age of 15 years.
Brüske I, Pei Z, Thiering E, Flexeder C, Berdel D, von Berg A, Koletzko S, Bauer CP, Hoffmann B, Heinrich J, Schulz H; GINIplus Study Group. Brüske I, et al. Pediatr Pulmonol. 2015 Dec;50(12):1262-9. doi: 10.1002/ppul.23196. Epub 2015 Apr 2. Pediatr Pulmonol. 2015. PMID: 25847609
Air pollution and cytokine responsiveness in asthmatic and non-asthmatic children.
Klümper C, Krämer U, Lehmann I, von Berg A, Berdel D, Herberth G, Beckmann C, Link E, Heinrich J, Hoffmann B, Schins RP; GINIplus and LISAplus study groups. Klümper C, et al. Among authors: link e. Environ Res. 2015 Apr;138:381-90. doi: 10.1016/j.envres.2015.02.034. Epub 2015 Mar 10. Environ Res. 2015. PMID: 25769127
Associations between ambient air pollution and bone turnover markers in 10-year old children: results from the GINIplus and LISAplus studies.
Liu C, Fuertes E, Flexeder C, Hofbauer LC, Berdel D, Hoffmann B, Kratzsch J, von Berg A, Heinrich J; GINIplus Study Group; LISAplus Study Group. Liu C, et al. Int J Hyg Environ Health. 2015 Jan;218(1):58-65. doi: 10.1016/j.ijheh.2014.07.006. Epub 2014 Aug 2. Int J Hyg Environ Health. 2015. PMID: 25153026 Free article.
Epidemiology of urticaria in infants and young children in Germany--results from the German LISAplus and GINIplus Birth Cohort Studies.
Brüske I, Standl M, Weidinger S, Klümper C, Hoffmann B, Schaaf B, Herbarth O, Lehmann I, von Berg A, Berdel D, Bauer CP, Koletzko S, Heinrich J; Giniplus And Lisaplus Study Groups. Brüske I, et al. Pediatr Allergy Immunol. 2014 Feb;25(1):36-42. doi: 10.1111/pai.12146. Epub 2013 Nov 17. Pediatr Allergy Immunol. 2014. PMID: 24236825
The associations between traffic-related air pollution and noise with blood pressure in children: results from the GINIplus and LISAplus studies.
Liu C, Fuertes E, Tiesler CM, Birk M, Babisch W, Bauer CP, Koletzko S, von Berg A, Hoffmann B, Heinrich J; GINIplus and LISAplus Study Groups. Liu C, et al. Int J Hyg Environ Health. 2014 Apr-May;217(4-5):499-505. doi: 10.1016/j.ijheh.2013.09.008. Epub 2013 Oct 9. Int J Hyg Environ Health. 2014. PMID: 24183515
Genome-wide association study (GWAS) for molar-incisor hypomineralization (MIH).
Kühnisch J, Thiering E, Heitmüller D, Tiesler CM, Grallert H, Heinrich-Weltzien R, Hickel R, Heinrich J; GINI-10 Plus Study Group; LISA-10Plus Study Group. Kühnisch J, et al. Clin Oral Investig. 2014;18(2):677-82. doi: 10.1007/s00784-013-1054-8. Epub 2013 Aug 7. Clin Oral Investig. 2014. PMID: 23918034
CONCLUSIONS: After considering the limitations of the present study (e.g., limited sample size and lack of an independent replication sample), it can be concluded that (1) replication analyses in an independent cohort study are strongly recommended and (2) large-scale and …
CONCLUSIONS: After considering the limitations of the present study (e.g., limited sample size and lack of an independent replication …
Peer problems are associated with elevated serum leptin levels in children.
Kohlboeck G, Romanos M, Tiesler C, Koletzko S, Kratzsch J, Thiery J, Bauer CP, von Berg A, Berdel D, Hoffmann B, Schaaf B, Lehmann I, Herbarth O, Heinrich J; GINI-plus Study Group; LISA-plus stuStudy Group. Kohlboeck G, et al. Psychol Med. 2014 Jan;44(2):255-65. doi: 10.1017/S003329171300069X. Epub 2013 Apr 8. Psychol Med. 2014. PMID: 23561045
Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study.
von Berg A, Filipiak-Pittroff B, Krämer U, Hoffmann B, Link E, Beckmann C, Hoffmann U, Reinhardt D, Grübl A, Heinrich J, Wichmann HE, Bauer CP, Koletzko S, Berdel D; GINIplus study group. von Berg A, et al. Among authors: link e. J Allergy Clin Immunol. 2013 Jun;131(6):1565-73. doi: 10.1016/j.jaci.2013.01.006. Epub 2013 Mar 16. J Allergy Clin Immunol. 2013. PMID: 23506844
207 results